Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease

NCT05229614

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +26 more
Locations: GSI Helmholtzzentrum für Schwerionenforschung GmbH Darmstadt, Germany

Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

National Center for Oncological Hadrontherapy (CNAO) Pavia, Italy

Fondazione IRCCS Policlinico San Matteo Pavia, Italy

View Trial Details

Recruiting

Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract

NCT05478876

Conditions: Gynecologic Cancer, Malignant Melanoma, Melanoma, +11 more
Locations: CNAO Pavia, Italy

View Trial Details

Recruiting

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

NCT06008106

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

NCT03755739

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +65 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guanzhou, Guangdong, China

View Trial Details

Recruiting

Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

NCT05649683

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: CHU de Nice - Hôpital de l'Archet Nice, Alpes-maritimes, France

CHU de Montpellier Montpellier, Occitanie, France

CHRU de Lille Lille, France

View Trial Details

Recruiting

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

NCT05539677

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +46 more
Locations: N.N. Petrov NMRC of Oncology, Oncoimmunology dep. Saint Petersburg, Russia

View Trial Details

Recruiting

Neoadjuvant Combination Immunotherapy for Stage III Melanoma

NCT03842943

Conditions: Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of Louisville Louisville, Kentucky, United States

View Trial Details

Recruiting

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

NCT03685890

Conditions: In-Transit Metastasis, Melanoma, Neoplasms, +10 more
Locations: Netherlands Cancer Institute Amsterdam, Netherlands

Erasmus MC Cancer Institute Groningen, Netherlands

Erasmus MC Cancer Institute Rotterdam, Netherlands

Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Recruiting

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

NCT06265025

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +47 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

Korea University Anam Hospital Seoul, South Korea

Hanyang University Seoul Hospital Seoul, South Korea

Severance Hospital, Yonsei University Health System Seoul, South Korea

View Trial Details

Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

NCT05280314

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations: Yale New Haven, Connecticut, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Massey Cancer Center Richmond, Virginia, United States

Melanoma Institute Australia The Uiniversity of Sydney, and Royal North Shore Hospital Sydney, New South Wales, Australia

View all 15 locations

View Trial Details